📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice. (2023)

First Author: Kordala AJ

Attributed to: Antisense Oligonucleotide Therapy for Neuromuscular Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202317683

PubMed Identifier: 37724723

Publication URI: http://europepmc.org/abstract/MED/37724723

Type: Journal Article/Review

Volume: 15

Parent Publication: EMBO molecular medicine

Issue: 11

ISSN: 1757-4676